Wockhardt Limited

Wockhardt Limited (WOCKPHARMA) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

wockhardt.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-09-02

Stock price
₹1904.30
Market cap
30,818 Cr
Stock P/E
78.4
P/B
5.85
Dividend yield
0.0%

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales753 Cr701 Cr700 Cr739 Cr809 Cr721 Cr743 Cr738 Cr782 Cr888 Cr965 Cr929 Cr
Operating expenses (approx.)681 Cr664 Cr803 Cr648 Cr699 Cr593 Cr679 Cr666 Cr604 Cr711 Cr740 Cr737 Cr
EBITDA72 Cr37 Cr-103 Cr91 Cr110 Cr128 Cr64 Cr72 Cr178 Cr177 Cr225 Cr192 Cr
OPM %9.6%5.3%-14.7%12.3%13.6%17.8%8.6%9.8%22.8%19.9%23.3%20.7%
Other income24 Cr8 Cr54 Cr30 Cr9 Cr8 Cr15 Cr20 Cr21 Cr25 Cr45 Cr31 Cr
Interest76 Cr77 Cr73 Cr73 Cr73 Cr60 Cr48 Cr48 Cr55 Cr60 Cr50 Cr52 Cr
Depreciation55 Cr55 Cr58 Cr54 Cr55 Cr55 Cr53 Cr56 Cr53 Cr65 Cr53 Cr55 Cr
Profit before tax-35 Cr-87 Cr-180 Cr-6 Cr-9 Cr21 Cr-22 Cr-109 Cr91 Cr67 Cr189 Cr116 Cr
Tax %-108.6%1.1%1.7%-166.7%-77.8%4.8%-104.5%0.9%9.9%9.0%13.2%7.8%
Net profit-73 Cr-86 Cr-177 Cr-16 Cr-16 Cr20 Cr-45 Cr-108 Cr82 Cr61 Cr164 Cr107 Cr
EPS (₹)₹-5.37₹-5.75₹-11.64₹-0.95₹-1.47₹0.91₹-1.57₹-5.53₹4.81₹3.61₹10.23₹6.55

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales4,158 Cr2,844 Cr2,708 Cr3,230 Cr2,651 Cr2,798 Cr3,012 Cr3,373 CrSign in for TTM
Operating expenses (approx.)4,049 Cr2,725 Cr2,771 Cr2,932 Cr2,550 Cr2,759 Cr2,619 Cr2,721 CrSign in for TTM
EBITDA110 Cr119 Cr-63 Cr298 Cr101 Cr39 Cr393 Cr652 CrSign in for TTM
OPM %2.6%4.2%-2.3%9.2%3.8%1.4%13.0%19.3%Sign in for TTM
Other income21 Cr39 Cr132 Cr20 Cr122 Cr83 Cr62 Cr111 CrSign in for TTM
Interest265 Cr276 Cr249 Cr299 Cr302 Cr305 Cr254 Cr213 CrSign in for TTM
Depreciation166 Cr224 Cr246 Cr247 Cr251 Cr223 Cr217 Cr227 CrSign in for TTM
Profit before tax-300 Cr-197 Cr916 Cr-411 Cr-624 Cr-420 Cr-16 Cr238 CrSign in for TTM
Tax %27.9%103.8%-29.7%32.1%0.5%-12.4%-256.3%16.4%Sign in for TTM
Net profit-217 Cr-43 Cr689 Cr-279 Cr-621 Cr-472 Cr-57 Cr199 CrSign in for TTM
EPS (₹)₹-17.58₹-6.25₹61.95₹-20.24₹-38.79₹-32.05₹-3.02₹13.12Sign in for TTM
Dividend payout %———————0.0%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital55 Cr55 Cr55 Cr72 Cr72 Cr77 Cr81 Cr81 Cr
Reserves2,619 Cr2,616 Cr3,321 Cr3,777 Cr3,282 Cr3,282 Cr4,272 Cr4,860 Cr
Borrowings2,453 Cr2,145 Cr1,569 Cr1,862 Cr1,887 Cr2,112 Cr1,859 Cr2,125 Cr
Other liabilities2,373 Cr2,977 Cr2,443 Cr2,179 Cr2,134 Cr1,875 Cr1,619 Cr1,209 Cr
Total liabilities7,831 Cr8,179 Cr7,773 Cr8,243 Cr7,683 Cr7,649 Cr8,135 Cr8,615 Cr
Fixed assets (net)2,125 Cr2,479 Cr2,311 Cr2,471 Cr2,022 Cr1,875 Cr1,718 Cr1,618 Cr
CWIP900 Cr836 Cr603 Cr389 Cr414 Cr434 Cr513 Cr671 Cr
Investments0.45 Cr0.45 Cr0.45 Cr0 Cr0 Cr0 Cr422 Cr412 Cr
Inventories819 Cr690 Cr799 Cr769 Cr658 Cr640 Cr725 Cr887 Cr
Trade receivables1,261 Cr1,243 Cr918 Cr918 Cr797 Cr618 Cr661 Cr588 Cr
Cash & bank397 Cr219 Cr232 Cr370 Cr90 Cr505 Cr112 Cr217 Cr
Other assets2,329 Cr2,711 Cr2,909 Cr3,326 Cr3,702 Cr3,577 Cr3,984 Cr4,222 Cr
Total assets7,831 Cr8,179 Cr7,773 Cr8,243 Cr7,683 Cr7,649 Cr8,135 Cr8,615 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity———413 Cr153 Cr219 Cr-22 Cr390 Cr
Cash from investing———-201 Cr-125 Cr-137 Cr-783 Cr-241 Cr
Cash from financing———-71 Cr-315 Cr334 Cr409 Cr-54 Cr
Net cash flow———138 Cr-280 Cr415 Cr-393 Cr105 Cr
Free cash flow (OCF − Capex)———201 Cr111 Cr160 Cr-387 Cr26 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %-1.3%3.0%34.5%-2.9%-5.8%-2.0%3.7%6.1%
ROE %-7.3%-2.6%20.3%-6.3%-15.3%-12.6%-1.0%4.0%
Debtor days110159123103109818063
Inventory days349405426457462377431479
Days payable358526308548609451352304
Cash conversion cycle1013924113-376159238
Debt / equity0.920.800.460.480.560.630.430.43
Current ratio0.980.680.730.760.560.741.211.61
Net debt / EBITDA0.000.00—0.0017.7941.214.452.93

Compare with peers

Loading peers…